Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection.
about
Targeting the Innate Immune Response to Improve Cardiac Graft Recovery after Heart Transplantation: Implications for the Donation after Cardiac DeathParticipation of blood vessel cells in human adaptive immune responsesRosacea: The cytokine and chemokine networkImmune-mediated vascular injury and dysfunction in transplant arteriosclerosisIntracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1α, controlling necrosis-induced sterile inflammationSterile inflammation: sensing and reacting to damageInterleukin 17 in vascular inflammation.Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice.Genome-wide comparison between IL-17 and combined TNF-alpha/IL-17 induced genes in primary murine hepatocytes.Human allograft rejection in humanized mice: a historical perspectiveThe critical role of SENP1-mediated GATA2 deSUMOylation in promoting endothelial activation in graft arteriosclerosisTh 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity.Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells.IFN-gamma primes intact human coronary arteries and cultured coronary smooth muscle cells to double-stranded RNA- and self-RNA-induced inflammatory responses by upregulating TLR3 and melanoma differentiation-associated gene 5.Beyond canonical inflammasomes: emerging pathways in IL-1-mediated autoinflammatory diseaseIs hypertension an autoimmune disease?Th17 cells and transplant acceptanceSynergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and interleukin-1 blockade: evidence of improved immune regulation.Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cellsIL-1 receptor signaling is required at multiple stages of sensitization and elicitation of the contact hypersensitivity responseThe IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitmentGenetically engineered islets and alternative sources of insulin-producing cells for treating autoimmune diabetes: quo vadis?Interleukin-1α Activity in Necrotic Endothelial Cells Is Controlled by Caspase-1 Cleavage of Interleukin-1 Receptor-2: IMPLICATIONS FOR ALLOGRAFT REJECTION.Interferon-γ-mediated allograft rejection exacerbates cardiovascular disease of hyperlipidemic murine transplant recipients.IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease.FGF regulates TGF-β signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression.Blocking MHC class II on human endothelium mitigates acute rejectionIL-1 Receptor Signaling on Graft Parenchymal Cells Regulates Memory and De Novo Donor-Reactive CD8 T Cell Responses to Cardiac AllograftsIntercellular adhesion molecule 1 mediates migration of Th1 and Th17 cells across human retinal vascular endotheliumThe impact of Th17 cells on transplant rejection and the induction of tolerance.Effects of immunosuppressive agents on Th17 cells involved in transplantation.CD4(+) T-cell subsets in transplantation.Processes of sterile inflammation.Inflammatory triggers of acute rejection of organ allografts.Taming inflammation by targeting cytokine signaling: new perspectives in the induction of transplantation tolerance.Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy.Experimental models of cardiac transplantation: design determines relevance.Humanized Mouse Models for Transplant Immunology.Emerging roles for RNA-binding proteins as effectors and regulators of cardiovascular disease.The importance of non-HLA antibodies in transplantation.
P2860
Q26744359-2DDADA7D-DAEB-47AB-922E-66760E70911CQ27021141-60F1E9F3-46D4-434A-90D5-D71A47B1CB48Q27023344-C77FCA48-26AF-4D46-9488-0FD8E966A550Q28084366-C4F7B1FD-046F-4C04-9CFA-7D29484F4507Q28591187-EDBE952C-ED0A-4A2E-877B-2CCD32E88D7FQ29620014-9A0A6831-E547-4041-8055-13525BEF8A8AQ30429445-C9BB2F40-33F4-49F1-B00C-80F5D2B486EDQ30432644-123F5A70-64DC-4B85-ADB9-B37786791E78Q33550592-F7692ABF-0C25-404A-B0B4-784EC6F1D506Q33577374-4B12F99A-D1E5-453F-8210-CF3C19C86C81Q33770904-3A5709CA-C5A1-4275-B3DE-7935E2AF6082Q33894387-991AECE6-AEE9-46CF-9563-9449FC5A7C2FQ33967700-4C65A391-B67F-44E2-A065-04CB809F9ACEQ33988307-E192D57E-02F4-45A0-92B6-AD21BA50D93DQ34307642-37E64FFF-D239-40B1-B367-7D6223D03774Q34311505-DBCCF2DB-14AF-432B-99E9-3405026A4380Q35327827-BAF1427A-E459-42E7-9A7D-A60745585413Q35612451-2096B533-B265-45F7-964A-20592389472FQ35613184-94CEB5A7-D8E9-41E0-A9C1-AD46D081ED91Q35740294-B71E81C0-753F-4332-9244-575585374551Q35915712-75484995-C4C7-4623-BC69-B2302C82B871Q36011576-D483107E-CF25-4783-AEA3-42BCDD939BADQ36139955-18892E49-9BF3-4932-A82D-72093F73B6D5Q36259538-31BC7138-0989-4F38-A1A2-CC1812219EA1Q36292874-ADCC8DAB-908E-46BA-BDB9-7C7424095956Q36501648-F10D3856-F0B1-4B54-82C7-3C8DB6B7FA99Q36588477-47D183C1-EA42-42CF-AF2C-B95837DB7DADQ36655827-732F4E1E-B87E-4ED6-81C9-7869B27ACE45Q37254740-B7D02F21-E007-4EFB-A3A8-3AD4A052DDAFQ37771228-B644D325-03D5-4179-94DC-6E5569B1D6B6Q38065208-F62096D1-BC5A-4BD3-89C7-3F26883B1761Q38081174-DA79DC16-F6EA-410D-8413-80308A353053Q38135408-5B23E09D-ED42-435D-84CF-50965F8EF17DQ38187172-5B2EB454-3DD9-4FF1-8DF5-6F54A089080DQ38217596-1EDC6ACC-6A1E-40C6-B61C-86F0CDDBAACEQ38218005-B5202CB5-A5B2-4E64-81F1-7C3C54DABB59Q38243702-1AD89C92-157D-414C-A9D3-98448F8393F4Q38640208-466E2D2A-E59F-4798-8686-94CAC8F6E710Q38773475-65F925B4-5AFD-4B0D-B836-9EFE83E5122BQ38877375-61B8E9F4-3430-4965-9B67-C8933315B661
P2860
Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interleukin (IL)-1 promotes al ...... del of human artery rejection.
@en
type
label
Interleukin (IL)-1 promotes al ...... del of human artery rejection.
@en
prefLabel
Interleukin (IL)-1 promotes al ...... del of human artery rejection.
@en
P2093
P2860
P356
P1476
Interleukin (IL)-1 promotes al ...... odel of human artery rejection
@en
P2093
George Tellides
Jordan S Pober
Lingfeng Qin
Nancy C Kirkiles-Smith
Raymond E Eid
P2860
P304
P356
10.1084/JEM.20081661
P407
P50
P577
2008-12-15T00:00:00Z